Korean J Anesthesiol.  2001 May;40(5):577-584. 10.4097/kjae.2001.40.5.577.

A Perioperative Thromboelastographic Coagulation Study of Patients Treated with a Massive Transfusion of Fluids and Packed Red Cells during Total Hip Replacement Surgery

Affiliations
  • 1Department of Anesthesiology, College of Medicine, InJe University, Seoul, Korea.

Abstract

BACKGROUND: The high incidence of deep vein thrombosis (DVT) of lower extremities and a subsequent pulmonary embolism (PE) makes it the most common cause of death following total hip replacement surgery. Therefore, the authors measured the perioperative changes in the blood coagulation activity with a thromboelastography (TEG) in the patients treated with fluid and packed red cells (PRC).
METHODS
Hemodilution was estimated with a measurement of hemoglobin (Hb), hematocrit (Hct), and platelet count. The changes in the coagulation factor activities were measured with TEG. Samples were obtained before skin incision (step 1); at the period that Hb and Hct ranged from about 10 g/dl to 30% (step 2); in the postanesthetic care unit (step 3); and on the postoperative first and third day (step 4, 5).
RESULTS
Although Hct and Hb decreased to 9.4% statistically at step 2 only, platelet counts were significantly decreased in step 2 (10.6%), 3 (34.5%), 4 (32.5%), and 5 (33.6%) compared with step 1 (P < 0.05). At step 2, there were no significant changes in TEG parameters except r time, which decreased (21.5%) (P < 0.05). At step 3, r time, alpha angle, and maximum amplitude (MA) decreased, and k time and lysis 60 increased (P < 0.05).
CONCLUSIONS
In spite of consumption and dilution of coagulation factors after massive fluids and PRC therapy during total hip replacement surgery, the increased activities of procoagulants and decreased fibrinolytic activities predisposed the body to initiate and maintain the thrombus.

Keyword

Complications: deep vein thrombosis; Monitoring: thromboelastography; Surgery: total hip replacement surgery

MeSH Terms

Arthroplasty, Replacement, Hip*
Blood Coagulation
Blood Coagulation Factors
Cause of Death
Hematocrit
Hemodilution
Humans
Incidence
Lower Extremity
Platelet Count
Pulmonary Embolism
Skin
Thrombelastography
Thrombosis
Venous Thrombosis
Blood Coagulation Factors
Full Text Links
  • KJAE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr